Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2025)

Historic Deferred Taxes for Organogenesis Holdings (ORGO) over the last 3 years, with Q3 2025 value amounting to -$3.8 million.

  • Organogenesis Holdings' Deferred Taxes fell 7456.78% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year change of. This contributed to the annual value of -$10.7 million for FY2024, which is 42373.91% down from last year.
  • Per Organogenesis Holdings' latest filing, its Deferred Taxes stood at -$3.8 million for Q3 2025, which was down 7456.78% from -$1.0 million recorded in Q2 2025.
  • Organogenesis Holdings' Deferred Taxes' 5-year high stood at $3.3 million during Q4 2023, with a 5-year trough of -$3.8 million in Q3 2025.
  • Its 3-year average for Deferred Taxes is -$1.3 million, with a median of -$1.7 million in 2024.
  • Its Deferred Taxes has fluctuated over the past 5 years, first crashed by 18553.31% in 2024, then tumbled by 7456.78% in 2025.
  • Quarter analysis of 3 years shows Organogenesis Holdings' Deferred Taxes stood at $3.3 million in 2023, then plummeted by 185.53% to -$2.8 million in 2024, then tumbled by 35.49% to -$3.8 million in 2025.
  • Its last three reported values are -$3.8 million in Q3 2025, -$1.0 million for Q2 2025, and -$1.3 million during Q1 2025.